Patent US5565322A successfully refreshed from Google Patents.
US5565322A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to donor energy transfer system
Assignee: Gamida for Life BV
•
Filing: 1992-11-06
•
Granted: 1996-10-15
•
Expires: 2012-11-06
Abstract
Abstract PCT No. PCT/US92/09827 Sec. 371 Date May 5, 1994 Sec. 102(e) Date May 5, 1994 PCT Filed Nov. 6, 1992 PCT Pub. No. WO93/09128 PCT Pub. Date May 13, 1993The presence invention contemplates chromophore-containing polynucleotides having at least two donor chromophores operatively linked to the polynucleotide by linker arms, such that the chromophores are positioned by linkage along the length of the polynucleotide at a donor-donor transfer distance, and at least one fluorescing acceptor chromophore operatively linked to the polynucleotide by a linker arm, such that the fluorescing acceptor chromophore is positioned by linkage at a donor-acceptor transfer distance from at least one of the donor chromophores, to form a photonic structure for collecting photonic energy and transferring the energy to an acceptor chromophore.
Inventors
- 👤 Michael J. Heller
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 21:14
CPC Classifications
G; G11; G11C; G11C13/00; G11C13/0002; G11C13/0009; G11C13/0014; G11C13/0019; B; B82; B82Y; B82Y10/00; C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/6818; C12Q1/6844; C12Q1/686; G06; G06N; G06N3/00; G06N3/12; G06N3/123; G11C13/04; H; H10; H10W; H10W72/00; H10W72/01; H10W72/0198; H10W90/00; B01; B01J; B01J2219/00; B01J2219/00274; B01J2219/00277; B01J2219/00497; B01J2219/00527; B01J2219/00536; B01J2219/00583; B01J2219/00603; B01J2219/00605; B01J2219/0061; B01J2219/00612; B01J2219/00614; B01J2219/00617; B01J2219/00623; B01J2219/00626; B01J2219/00659; G11B; G11B7/00; G11B7/24; G11B7/241; G11B7/242; G11B7/244; G11B7/246; G11B2007/24624; Y; Y10; Y10S; Y10S435/00; Y10S435/80; Y10S436/00; Y10S436/80; Y10T; Y10T436/00; Y10T436/13
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
158 words
A duplex nucleic acid structure capable of extended photonic energy transfer, said structure comprising: a first polynucleotide; a second polynucleotide hybridized to said first polynucleotide; a terminal donor chromophore linked by linker arms to one of said first polynucleotide and said second polynucleotide; at least one intermediate donor chromophore linked by linker arms to one of said first polynucleotide and said second polynucleotide; and at least one acceptor chromophore linked by linker arms to one of said first polynucleotide and said second polynucleotide; wherein the distance between said terminal donor chromophore and one said acceptor chromophore is greater than 5 nm and there is at least one said intermediate donor chromophore spaced from said terminal donor chromophore by a donor-donor transfer distance; and wherein said donor and said acceptor chromophores are alternately positioned on said first polynucleotide and said second polynucleotide such that said photonic energy transfer crosses between said first and said second polynucleotides of said duplex.
Claim 2
Dependent Claim
158 words
A duplex nucleic acid structure capable of extended photonic energy transfer, said structure comprising: a first polynucleotide; a second polynucleotide hybridized to said first polynucleotide; a terminal donor chromophore linked by linker arms to one of said first polynucleotide and said second polynucleotide; at least one intermediate donor chromophore linked by linker arms to one of said first polynucleotide and said second polynucleotide; and at least one acceptor chromophore linked by linker arms to one of said first polynucleotide and said second polynucleotide; wherein the distance between said terminal donor chromophore and one said acceptor chromophore is greater than 5 nm and there is at least one said intermediate donor chromophore spaced from said terminal donor chromophore by a donor-donor transfer distance; and wherein said donor and said acceptor chromophores are alternately positioned on said first polynucleotide and said second polynucleotide such that said photonic energy transfer crosses between said first and said second polynucleotides of said duplex.
Claim 3
Dependent Claim
15 words
The structure of claim 1, wherein said donor-donor transfer distance is 1.4 to 6.1 nm.
Claim 4
Dependent Claim
52 words
The structure of claim 1, wherein said donor chromophores are selected from the group consisting of 4,4'-diisothiocyanatodihydro-stilbene-2,2'-disulfonic acid, 4-acetamido-4'-isothiocyanato-stilbene-2,2'-disulfonic acid, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid, succinimidyl pyrene butyrate, acridine isothiocyanate, 4-dimethylaminophenylazophenyl-4'-isothiocyanate (DABITC), Lucifer Yellow vinyl sulfone, fluorescein isothiocyanate, Reactive Red 4 (Cibacron® Brilliant Red 3B-A) rhodamine X isothiocyanate, sulforhodamine 101, Malachite Green isothiocyanate and IR1446.
Claim 5
Dependent Claim
12 words
The structure of claim 1, wherein said donor chromophores are non-fluorescing chromophores.
Claim 6
Dependent Claim
18 words
The structure of claim 1, wherein said at least one intermediate donor chromophore comprises 1 to 99 chromophores.
Claim 7
Dependent Claim
55 words
The structure of claim 1, further comprising at least one fluorescing acceptor chromophore operatively linked by linker arms to one of said first polynucleotide and said second polynucleotide, wherein said at least one fluorescing accepting chromophore is positioned by said linker arms at a donor-acceptor transfer distance from at least one of said donor chromophores.
Claim 8
Dependent Claim
15 words
The structure of claim 6, wherein said donor-acceptor transfer distance is 0.1 to 1.7 nm.
Claim 9
Dependent Claim
29 words
The structure of claim 6, wherein said fluorescing acceptor chromophore is selected from the group consisting of pyrene, Lucifer Yellow, acridine, riboflavin, fluorescein, rhodamine, sulforhodamine 101, and IR 144.
Claim 10
Dependent Claim
23 words
The structure of claim 1, wherein at least one of said first polynucleotide and said second polynucleotide is linked to a solid support.
Claim 11
Dependent Claim
24 words
The structure of claim 9, wherein the solid support is selected from the group consisting of glass, metals, silicon, organic polymers, membranes, and bio-polymers.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-10-15 | 2000-04-15 | 2000-10-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-10-15 | 2004-04-15 | 2004-10-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-10-15 | 2008-04-15 | 2008-10-15 | $7700.00 | Window Closed / Lapsed |